The clinical implications, however, depend on whether the mechanism translates to humans and whether the doses used produce meaningful c-Met activation in human brain tissue
Evidence indicates it may reduce treatment-related adverse effects and improve quality of life when used alongside conventional therapies, including in chronic inflammatory conditions and oncology settings, provided careful monitoring for drugnutrient interactions ( in vivo antioxidant, anti-inflammatory, immunomodulatory, antiviral, and anticancer effects
10.1199/tab.0142 107 NohS.GoA.KimD
20, 21, 22, 23, 24, 25, 26, 27, 28 PSCs, not only can secrete various inflammatory cytokines/chemokines, 29, 30, 31 which can participate in inflammatory processes, they can also proliferate and secrete collagen